Skip to main content

  • Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients

    • Posted: 03/03/2020
    • Author:

      Michael Megaly, Abdelrahman Ali, Bishoy Abraham, Charl Khalil, Magdi Zordok, Marco Shaker, Mariam Tawadros, Bassam S. Hennawy, Ayman Elbadawi, Mohamed Omer and Marwan Saad

    • CRM2020

    Highlights

    • Percutaneous coronary intervention in patients with diabetes mellitus remains associated with inferior clinical outcomes with non-diabetic patients even in the era of drug-eluting stents (DES).
    • We performed a meta-analysis of all published studies reporting the outcomes with drug-coated balloons (DCBs) vs. DES after de-novo coronary PCI in diabetic patients.
    • DCBs are associated with similar clinical and angiographic outcomes compared with first-generation DES in diabetic patients,
    • DCBs might be associated with a potential reduction in TLR, but this needs a large RCT powered to identify that benefit

    Abstract

    Background

    Percutaneous coronary intervention (PCI) in patients with diabetes mellitus (DM) remains associated with inferior clinical outcomes and an increased risk of restenosis compared with non-diabetics even in the era of drug-eluting stents (DES). The outcomes with drug-coated balloons (DCBs) in diabetic patients have received limited study.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details